Musk’s new company could top a trillion?

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

Sophie V. Vandebroek net worth and biography

Sophie Vandebroek Biography and Net Worth

Director of IDEXX Laboratories

Dr. Vandebroek has served as founder and owner of Strategic Vision Ventures LLC since February 2021. Previously, Dr. Vandebroek was the inaugural visiting scholar at the Massachusetts Institute of Technology School of Engineering for the 2019-2020 academic year; Vice President, Emerging Technology Partnerships for International Business Machines, Inc. (IBM) from August 2018 to August 2019 and Chief Operating Officer - IBM Research from January 2017 to August 2018. Prior to joining IBM, she was an executive with Xerox Corporation where she served as Chief Technology Officer and Corporate Vice President of Xerox Corporation and President of the Xerox Innovation Group from 2006 to 2016 and was Chief Engineer of Xerox Corporation from 2002 to 2005. Dr. Vandebroek was also responsible for overseeing Xerox’s global research centers, including the Palo Alto Research Center, or PARC Inc. Dr. Vandebroek has been a member of the Supervisory Board of Wolters Kluwer N.V. since April 2020. Dr. Vandebroek previously served as a director of Analogic Corporation from 2008 to 2016. Dr. Vandebroek has been a member of the Advisory Council of the dean of the School of Engineering at Massachusetts Institute of Technology since 2010. She is a Fellow of the Institute of Electrical & Electronics Engineers, a Fulbright Fellow and a Fellow of the Belgian-American Educational Foundation. Dr. Vandebroek holds an undergraduate degree in engineering and a master’s degree in electro-mechanical engineering from KU Leuven, Leuven, Belgium, and a Ph.D. in electrical engineering from Cornell University.

What is Sophie V. Vandebroek's net worth?: The estimated net worth of Sophie V. Vandebroek is at least $389,846.85 as of November 27th, 2024. Vandebroek owns 905 shares of IDEXX Laboratories stock worth more than $389,847 as of December 3rd. This net worth approximation does not reflect any other investments that Vandebroek may own. Learn More about Sophie V. Vandebroek's net worth.
How do I contact Sophie V. Vandebroek?: The corporate mailing address for Vandebroek and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Sophie V. Vandebroek's contact information.
Has Sophie V. Vandebroek been buying or selling shares of IDEXX Laboratories?: During the last ninety days, Sophie V. Vandebroek has sold $144,631.36 in shares of IDEXX Laboratories stock. Most recently, Sophie V. Vandebroek sold 344 shares of the business's stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $420.44, for a transaction totalling $144,631.36. Following the completion of the sale, the director now directly owns 905 shares of the company's stock, valued at $380,498.20. Learn More on Sophie V. Vandebroek's trading history.
Who are IDEXX Laboratories' active insiders?: IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.
Are insiders buying or selling shares of IDEXX Laboratories?: During the last year, insiders at the sold shares 7 times. They sold a total of 62,832 shares worth more than $34,853,319.72. The most recent insider tranaction occured on November, 27th when Director Sophie V Vandebroek sold 344 shares worth more than $144,631.36. Insiders at IDEXX Laboratories own 2.2% of the company. Learn More about insider trades at IDEXX Laboratories.
Information on this page was last updated on 11/27/2024.

Sophie V. Vandebroek Insider Trading History at IDEXX Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/27/2024	Sell	344	$420.44	$144,631.36	905
5/4/2023	Sell	2,187	$469.02	$1,025,746.74	872
2/12/2021	Sell	3,046	$538.20	$1,639,357.20	6,367
8/5/2019	Sell	9,044	$263.86	$2,386,349.84	12,116

Sophie V. Vandebroek Buying and Selling Activity at IDEXX Laboratories

IDEXX Laboratories Company Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Today's Range

Now: $434.12

$423.44

$434.98

50 Day Range

MA: $451.91

$406.92

$511.78

2 Week Range

Now: $434.12

$398.50

$583.39

Volume

203,346 shs

Average Volume

505,242 shs

Market Capitalization

$35.55 billion

P/E Ratio

41.86

Dividend Yield

N/A

Beta

1.37